These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36730186)

  • 1. Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.
    Nguyen HT; Van Duong T; Taylor LS
    Mol Pharm; 2023 Mar; 20(3):1681-1695. PubMed ID: 36730186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric coating of tablets containing an amorphous solid dispersion of an enteric polymer and a weakly basic drug: A strategy to enhance in vitro release.
    Nguyen HT; Van Duong T; Taylor LS
    Int J Pharm; 2023 Jul; 642():123139. PubMed ID: 37311499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
    Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS
    Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining enabling formulation strategies to generate supersaturated solutions of delamanid: In situ salt formation during amorphous solid dispersion fabrication for more robust release profiles.
    Duong TV; Nguyen HT; Taylor LS
    Eur J Pharm Biopharm; 2022 May; 174():131-143. PubMed ID: 35413402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
    Butreddy A
    Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An enteric polymer mitigates the effects of gastric pH on oral absorption of poorly soluble weak acid drugs from supersaturable formulations: A case study with dantrolene.
    Kataoka M; Nakanishi R; Umesaki M; Kobayashi M; Minami K; Higashino H; Yamaguchi S; Yamashita S
    Eur J Pharm Biopharm; 2020 Oct; 155():29-36. PubMed ID: 32771692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
    Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
    Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of Drug-Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions.
    Bapat P; Paul S; Tseng YC; Taylor LS
    Mol Pharm; 2024 Mar; 21(3):1466-1478. PubMed ID: 38346390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
    Bapat P; Paul S; Thakral NK; Tseng YC; Taylor LS
    Mol Pharm; 2023 Nov; 20(11):5714-5727. PubMed ID: 37751517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailoring supersaturation from amorphous solid dispersions.
    Li N; Taylor LS
    J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Polymers on the Physical and Chemical Stability of Spray-dried Amorphous Solid Dispersion: Dipyridamole Degradation Induced by Enteric Polymers.
    Peng T; She Y; Zhu C; Shi Y; Huang Y; Niu B; Bai X; Pan X; Wu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2620-2628. PubMed ID: 29916195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media.
    Li N; Ormes JD; Taylor LS
    Pharm Res; 2016 Jul; 33(7):1723-35. PubMed ID: 27026009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation.
    Bhujbal SV; Pathak V; Zemlyanov DY; Taylor LS; Zhou QT
    J Pharm Sci; 2021 Jun; 110(6):2423-2431. PubMed ID: 33387599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
    Ojo AT; Ma C; Lee PI
    Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric Polymer-Based Amorphous Solid Dispersions Enhance Oral Absorption of the Weakly Basic Drug Nintedanib via Stabilization of Supersaturation.
    Qin Y; Xiao C; Li X; Huang J; Si L; Sun M
    Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Dependent supersaturation from amorphous solid dispersions of weakly basic drugs.
    Wang B; Nethercott MJ; Narula A; Hanrahan M; Kuang S; Wenslow RM; Li N
    Pharm Res; 2022 Nov; 39(11):2919-2936. PubMed ID: 34890018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.